NOVARTIS INDIA
Back to Cashflow Statement
|
NOVARTIS INDIA Last 5 Year Cash Flow from Financing Activities History
[Standalone]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-64 Cr | ₹-121 Cr | ₹-30 Cr | ₹-36 Cr | ₹-37 Cr |
What is the latest Cash Flow from Financing Activities ratio of NOVARTIS INDIA ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2025 | ₹-64 Cr |
Mar2024 | ₹-121 Cr |
Mar2023 | ₹-30 Cr |
Mar2022 | ₹-36 Cr |
Mar2021 | ₹-37 Cr |
How is Cash Flow from Financing Activities of NOVARTIS INDIA Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2025 | ₹-64 Cr | Negative | |
Mar2024 | ₹-121 Cr | Negative | |
Mar2023 | ₹-30 Cr | Negative | |
Mar2022 | ₹-36 Cr | Negative | |
Mar2021 | ₹-37 Cr | - |
Compare Cash Flow from Financing Activities of peers of NOVARTIS INDIA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NOVARTIS INDIA | ₹2,516.4 Cr | -4.4% | 0.8% | -9.2% | Stock Analytics | |
ADANI ENTERPRISES | ₹294,310.0 Cr | -2.6% | -1.4% | -12.2% | Stock Analytics | |
REDINGTON | ₹23,007.6 Cr | -3.1% | -1% | 42.9% | Stock Analytics | |
LLOYDS ENTERPRISES | ₹10,121.0 Cr | -3.3% | -1.1% | 126.9% | Stock Analytics | |
MMTC | ₹10,057.5 Cr | -5.3% | -5.7% | -33.1% | Stock Analytics | |
HONASA CONSUMER | ₹8,573.5 Cr | -6.3% | -15.8% | -40.9% | Stock Analytics |
NOVARTIS INDIA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NOVARTIS INDIA | -4.4% |
0.8% |
-9.2% |
SENSEX | -0.4% |
-1.6% |
1.3% |
You may also like the below Video Courses